Gene Therapy 2.0: Leveraging Transgene Cassette Engineering

Novel gene therapies are entering the clinic and generating clinical data readouts at an unprecedented rate. As with any new therapy, the key readouts are safety and efficacy. While there has been substantial progress and clinical success, the gene therapy field must continue to refine the engineering of viral vectors for increased manufacturability, targeted efficacy, and safety. Exclusively designed for experts working in the Gene Therapy space, this exclusive 1-hour symposium will allow you to: -Get up to speed with AI and Machine learning for vector engineering and how it can optimize viral vectors -Discover how to enhance therapeutic efficacy with targeted tissue and cell expression -Delve into the impact of transgene cassette optimization to understand the next generation of viral vector manufacturing